Antibodies

LIVE May 20th, 2021 at 2:30 PM ET
In this webinar, Berkeley Lights scientists present a new platform for antibody discovery and cell line development that accelerates the identification and production of leading therapeutic molecules.

Therapeutic candidates retain binding to major COVID-19-causing “South African” variant

Inhalable Antibodies for SARS-CoV-2

The anti-CD117 antibody is being evaluated as a conditioning agent prior to blood stem cell transplantation

Two leading scientists call on health agencies to invest in broadly effective vaccines

Quantifying biotherapeutics in biological matrices plays a critical role in the drug discovery and development process. Ligand binding assays often lack the sensitivity to detect low-concentration analytes, particularly with limited sample supply.  

UCLA researchers to select candidates for development with Xencor’s modular XmAb platforms

Find out about new offerings from BioTek, Repligen, Flow Eighteen38, and Cresset

DIOS-202 and DIOS-203 have been engineered for high potency and potential for avoiding escape mutants